Inolimomab

Inolimomab is a mouse monoclonal antibody developed as an immunosuppressive drug against graft-versus-host disease. Its target is the alpha chain of the interleukin-2 receptor.^[1][2]

Inolimomab

Monoclonal antibody
Type	Whole antibody
Source	Mouse
Target	CD25
Clinical data
ATC code	none
Identifiers
CAS Number	152981-31-2 N
ChemSpider	none
UNII	GO90DFK14U
NY (what is this?)  (verify)